View
Page
"Futura Medical is at an exciting juncture, with further CSD500 (erectogenic condom) product launches through partners expected in H2 2016 and pivotal headline Eroxon® (topical treatment of erectile dysfunction) data due in Q3 2016. Discussions are also ongoing with potential licensing partners for the group’s topical pain relief products TRP100 (diclofenac) and TIB200 (ibuprofen) and we continue to expect the submission of regulatory dossiers for both products by the year-end. We look forward to the developments in H2 2016." N+1 Singer note out this morning on research tree
Latest from the Community...
Latest from the Community...
Latest from the Community...
